Acerus Pharmaceuticals SRL
Records under this name other than patents Acerus Pharmaceuticals SRL holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 9 of 9 · Back to Acerus Pharmaceuticals SRL
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,090,312 | Methods of Treating Hypogonadism With Transnasal Testerosterone Bio-Adhesive Gel Formulations in Male With Allergic Rhinitis, And Methods for Preventing An Allergic Rhinitis Event Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,744,838 | Methods of Treating Hypogonadism with Transnasal Testosterone Bio-Adhesive Gel Formulations in Male with Allergic Rhinitis, and Methods for Preventing an Allergic Rhinitis Event Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 10,111,888 | Intranasal 0.15% and 0.24% Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder Formerly held Lapsed on the fee record Ended Oct 30, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 30, 2026 | Low confidence |
| US 7,661,425 | Inhaler Formerly held Term ended Term ended Jun 16, 2026 · High confidence | Term ended | Term ended Jun 16, 2026 | High confidence |
| US 9,757,388 | Intranasal Methods of Treating Women for Anorgasmia with 0.6% and 0.72% Testosterone Gels Lapsed on the fee record Ended Sep 12, 2025 · High confidence | Lapsed on the fee record | Ended Sep 12, 2025 | High confidence |
| US 10,668,084 | Intranasal Lower Dosage Strength Testosterone Gel Formulations and Use Thereof for Treating Anorgasmia or Hypoactive Sexual Desire Disorder Formerly held Lapsed on the fee record Ended Jun 2, 2024 · High confidence | Lapsed on the fee record | Ended Jun 2, 2024 | High confidence |
| US 6,648,848 | Inhaler for powdered medicaments Formerly held Term ended Term ended Jan 12, 2020 · USPTO record | Term ended | Term ended Jan 12, 2020 | USPTO record |
| US 6,811,543 | Method for Introducing a Powdered Substance into a Nostril Formerly held Term ended Term ended Sep 17, 2018 · Medium confidence | Term ended | Term ended Sep 17, 2018 | Medium confidence |
| US 5,797,392 | Inhaler Formerly held Term ended Term ended no later than Aug 25, 2018 · Low confidence | Term ended | Term ended no later than Aug 25, 2018 | Low confidence |